跳到正文
openFDA 已分级药品召回执法报告·· 19 天前AI 评分52

FDA 执法报告 D-0107-2027 将 Direct Rx 利多卡因软膏 5.0% 含量不足召回列为 II 类

FDA drug enforcement D-0107-2027: Direct Rx — Subpotent Drug

AI 导读

FDA 药品召回执法报告 D-0107-2027 将 Direct Rx 的利多卡因软膏 USP 5.0%(50g 罐装,NDC 72189-0211-50)因含量不足列为 II 类召回。

正文 · 原文

FDA drug recall enforcement report — D-0107-2027

Report issued: 2026-11-04. This is the enforcement report date, not the recall initiation date.

Scope: one classified drug product recall record; event_id may group multiple products. Unclassified records without recall numbers are outside this stream. This record is not a press release or a new enforcement finding.

The openFDA dataset is updated weekly. Report status is not a live recall status and must not be used to track the recall lifecycle. Other dates below retain their named meanings.

Complete official product record (including openFDA harmonized identifiers):

{

"address_1": "94 Worldwide Dr",

"address_2": "",

"center_classification_date": "20261029",

"city": "Dawsonville",

"classification": "Class II",

"code_info": "LOT#: 03AP2511, 30AP2518, 18JU2519, 18JU2520, Exp. Date 04/30/2027.",

"country": "United States",

"distribution_pattern": "Nationwide within the United States",

"event_id": "100229",

"initial_firm_notification": "Letter",

"more_code_info": "",

"openfda": {},

"postal_code": "30534-6828",

"product_description": "Lidocaine Ointment USP, 5.0 % 50g JAR, Rx only, Packaged and Distributed by: Direct Rx Dawsonville, GA 30534, NDC 72189-0211-50",

"product_quantity": "493 jars",

"product_type": "Drugs",

"reason_for_recall": "Subpotent Drug",

"recall_initiation_date": "20260929",

"recall_number": "D-0107-2027",

"recalling_firm": "Direct Rx",

"report_date": "20261104",

"state": "GA",

"status": "Ongoing",

"voluntary_mandated": "Voluntary: Firm initiated"

}

来源:openFDA 已分级药品召回执法报告 · api.fda.gov